Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended December 31, 2021
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Zeal ShahDesignation :- Company Secretary and Compliance Officer Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to above captioned subject, on the basis of confirmation received from our Registrar and Transfer Agent, Kfin Technologies Private Limited, we confirm that the details of securities dematerialised during the quarter ended 31.12.2021 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to the stock exchanges where the shares of the Company are listed within the prescribed time period. We enclose herewith the copy of letter received from Kfin Technologies Private Limited confirming the above. Kindly acknowledge receipt. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Private Limited, regarding the loss /misplacement of the share certificate(s). We request you to take the same on record and acknowledge receipt. Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended December 31, 2021
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 9, 2022, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31, 2021.
India medical regulator flags major' worries over Merck Covid-19 drug
While the drug regulator last week approved Merck's molnupiravir for emergency use, the director general of Indian Council of Medical Research said the drug has major safety concerns.The FDA cautioned that Merck's drug isn't recommended for use by those who are pregnant Molnupiravir being studied further to be included in Covid-19 treatment protocol
DCGI had approved Merck's new drug for restricted emergency use Procter & Gamble Health Ltd - 500126 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Procter & Gamble Health Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
Sub: Intimation of closure of Trading Window We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from January 1, 2022 until 48 hours from the publication of the unaudited financial results. Kindly take the same on record. Procter & Gamble Health Ltd - 500126 - Appointment Of Mr. S. Madhavan (DIN 06451889) As A Non-Executive Independent Director Of The Company For A Period Of Five Years.
With reference to our letter dated November 09, 2021 regarding appointment of Mr. S. Madhavan as a Non-Executive Independent Director of the Company for a period of five years, effective November 15, 2021, subject to the approval of the Shareholders of the Company. We are pleased to inform you that the Shareholders have approved such appointment on December 29, 2021 via Postal Ballot held by the Company. Kindly take the above on record and oblige